Home
Adalvo

Adalvo Market Share Analysis for May 2026

adalvo is a global pharmaceutical company with a declared purpose to make a difference for patients around the world driven by our smart collaboration network and commitment to deliver highest quality differentiated products and services to our partners.

Industry: N/A

Domainadalvo.com

Year Founded2020

Employees201 - 500

Annual Revenue--

Adalvo

Adalvo (including company regionals)

adalvo.com

See more website traffic and engagement information

Total visits to Adalvo's top domains

Understand Adalvo market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

adalvo.com3.6K

See more with Sales Intelligence

Avg. visit duration in Adalvo's top domains

Analyze Adalvo engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

adalvo.com00:00:10

See more with Sales Intelligence

Avg. pageviews on Adalvo's top domains

See how Adalvo keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

adalvo.com2.05

See more with Sales Intelligence

Adalvo top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Adalvo

These are the website technologies, by industry, used by Adalvo top domains

Social (3)

Instagram

Advertising (2)

DoubleClick

Email Services (2)

Microsoft Exchange Online

Mobile (2)

Meta Viewport

More Technologies

5

See all

News & Signals from Adalvo

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAdalvo Limited is developing generic linagliptin/metformin fixed-dose combination tablet on Jun 24th '26.Adalvo is preparing filings for its generic linagliptin/metformin fixed-dose combination (FDC) tablet across multiple regions, including Europe via the DCP.

NewsAdalvo Limited hired Rannveig Borg Sigurðardóttir as Chief Legal Officer on Jun 9th '26.Adalvo, the global B2B pharmaceutical company operating across 140+ markets, announces the appointment of Rannveig Borg Sigurðardóttir as Chief Legal Officer.

NewsAdalvo Limited hired Rannveig as Chief Legal Officer on Jun 8th '26.Rannveig joins a senior leadership team driving Adalvo's next phase of international expansion, with a growing portfolio spanning over 170 commercial partners worldwide.